Drugs / mouse tyrosinase
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00698100 | Jun 2002 → Sep 2011 | melanoma | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mouse tyrosinase | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00698100 ↗ |
| Modality | Vaccine | “mouse tyrosinase DNA vaccination” NCT00698100 ↗ |